ACY3 Antibody [DyLight 488]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-99167G
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunocytochemistry/ Immunofluorescence, Immunohistochemistry-Paraffin
Label
DyLight 488 (Excitation = 493 nm, Emission = 518 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Produced in rabbits immunized with a synthetic peptide corresponding to the C-terminus of the Human ACY3.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for ACY3 Antibody [DyLight 488]
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen and protein A Affinity-purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: ACY3
Alternate Names
ACY-3aspartoacylase-2, Acylase III, aminoacylase-3, aspartoacylase (aminocyclase) 3, EC 3.5.1.-, EC 3.5.1.15, HCBP1ASPA2, Hepatitis C virus core-binding protein 1, MGC9740
Gene Symbol
ACY3
Additional ACY3 Products
Product Documents for ACY3 Antibody [DyLight 488]
Product Specific Notices for ACY3 Antibody [DyLight 488]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...